A new study has revealed that the risk of taste and smell disorders may increase by about 50 percent in people taking the popular weight loss injections Mounjaro and Ozempic.
According to the study, although these drugs have been shown to be effective in reducing body weight by about 15 percent on average by reducing appetite.
However, their use may also change the ability to taste and smell foods in some people.
Experts said that about two people in every 1,000 people with type 2 diabetes usually experience changes in their sense of taste and smell, but these drugs belonging to the GLP-1 group can almost double this risk.
Experts say that although the possibility of this side effect is low. However, people using weight loss drugs should definitely consult their doctor if they experience an unusual change in their sense of taste or smell.
Read also: Quitting sugar completely may harm health, new study finds
